🇺🇸 FDA
Pipeline program

Shenfu Injection

2024109

Approved small_molecule active

Quick answer

Shenfu Injection for Septic Cardiomyopathy is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Septic Cardiomyopathy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials